MY ACCOUNT | NEWSLETTER |

NIHC argues for hemp in animal feed


The National Industrial Hemp Council of America has suggested the inclusion of hemp into animal feed. The hemp member organization, NIHC, sent two letters: once each to the FDA’s Center for Veterinary Medicine and the Association of American Feed Control Officials (AAFCO) requesting a webinar with the organizations as well as USDA to begin a discussion about allowing for hemp in animal feed. 

The letter also provided research information about the safety of hemp in the animal feed supply chain in the US, according to NIHC. 

“We believe that there is a clear solution and path forward to the approval of hemp feed through the utilization of existing research and the establishment of appropriate agency barriers,” said Hunter Buffington, a member of NIHC's Government Affairs Committee. “It is incredibly disappointing that some choose to create confusion over feed ingredients versus animal supplements at the expense of American ranchers and farmers who need a safe, affordable and nutritious supply of animal feed that hempseed provides.”

The letters followed action by AAFCO and additional animal feed and animal nutrition groups, and veterinarians to stop the inclusion of hemp in feed. The collaborative groups asked states to no longer pass legislation allowing for hemp in feed. FDA-CVM also called for research pointing to hemp’s safety be conducted only within the US, a request that would exclude decades of research, according to NIHC.

"At a time when the global supply chain has been so severely disrupted, hemp as a commodity can be an answer," said Buffington. "There is no reason homegrown hemp can't support the American livestock industry."

NIHC offered information to clarify hemp’s use in animal feed, namely that hemp cannot create cannabinoids and is separate from CBD. Further, NIHC suggested that FDA-CVM give priority to ingredient approvals for AAFCO and create a pathway for ingredients that utilize existing research, that research be applicable if conducted in the US before 2014 when a bill allowed hemp to be researched in the US, that regulatory agencies collaborate to speed approval of existing methods to measure cannabinoids in seed and to measure transference in by-products, and that FDA-CVM set limits for cannabinoids in seed products.


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

One Committed and Caring NC State Veterinary Student, So Many Choices

Like0
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top